Production (Stage)
Shanrong Biotechnology Corp.
SRBT
$0.28
-$0.188-40.17%
OTC PK
| 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | 12/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -2,308.46% | 141.19% | 39.92% | 27.60% | -93.20% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -66.67% |
| Total Other Non-Cash Items | -- | -- | -100.00% | -47.94% | 200.00% |
| Change in Net Operating Assets | 210.51% | -239.67% | -60.85% | 2.00% | 564.75% |
| Cash from Operations | -147.35% | 32.94% | -80.75% | 70.91% | 17.67% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Investing | 200.00% | -- | -- | -- | -- |
| Total Debt Issued | -106.40% | 120.00% | 194.76% | -93.99% | -5.81% |
| Total Debt Repaid | -79.66% | 67.58% | 4.71% | 88.57% | -708.93% |
| Issuance of Common Stock | -- | -- | -100.00% | -19.35% | 244.44% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 159.18% | 340.97% | -86.79% | -34.18% | -35.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 731.43% | 97.96% | -240.24% | 651.80% | -127.51% |